C O M M U N I C A T I O N S
Scheme 2. Synthesis of GS Analogues 9a and 9ba
peptide backbone, including the remaining two intramolecular
hydrogen bonds, is only minimally perturbed by this movement of
the plane of the trisubstituted alkene. The ornithine side chains
extend in an orthogonal fashion away from the perimeter of the
â-sheet, a feature that is essential for antibiotic activity.6,8 Indeed,
the Orn-δ-amino deprotected 1a and 1b demonstrated functional
mimicry of the natural product with MICs of 5-15 µg/mL,
equivalent to GS, against Bacillus subtilis.18
In conclusion, a concise synthetic strategy was used for the first
preparation of GS analogues with trisubstituted (E)-alkene peptide
bond replacements. Solution and solid state conformational analysis
demonstrated that the bistrifluoromethylated analogue 9b was a
superior mimic of the natural product, whereas the incorporation
of methyl groups into the alkene peptide isostere 9a led to a far
greater perturbation of the secondary structure features of GS. The
difference between CF3- and CH3-substitution can be explained by
the enhanced electrostatic carbonyl group mimicry of the former
function.
a (a) H-Pro-Val-Orn(Cbz)-OMe (10), EDC, HOBt, DMAP; 7a, 94% from
5a; 7b, 77% from 5b; (b) 1.0 N NaOH; (c) 4.0 N HCl in dioxane; (d)
EDC, HOBt, DMAP; 8a, 97% from 7a; 8b, 85% from 7b; (e) (i) 1.0 N
NaOH; (ii) 4.0 N HCl in dioxane; (iii) EDC, HOBt, DMAP; 9a, 42%; 9b,
42% (after reverse phase semi-prep HPLC purification).
Acknowledgment. Support from the NIGMS CMLD program
(P50-GM067082) for this project is gratefully acknowledged. We
thank Prof. A. Rheingold (UCSD) and Dr. S. J. Geib (Pittsburgh)
for the X-ray crystallographic analysis. J.X. gratefully acknowledges
an Andrew W. Mellon Predoctoral Fellowship for support, and Dr.
Corey R. J. Stephenson for helpful discussion.
Table 1. Tabular Display of Amide Proton Temperature Shift
Coefficients (∆δ/∆T) of 9a, 9b, and Cbz2GS in DMSO-d6 [ppb/K]
Cbz2GS
9a
9b
Orn-NH
Leu-NH
Orn-δ-NH
Val-NH
-6.7
-3.8
-8.6
-2.2
-11.8
-7.0
-3.1
-8.4
-0.4
N/A
-4.6
-2.9
N/Aa
-0.01
N/A
Supporting Information Available: Crystal information files (CIF)
for compounds 5a and 9b. Experimental procedures, 1H and 13C spectra
for selected compounds. This material is available free of charge via
DPhe-NH
1
a Signal obscured in H NMR.
References
(1) Bursavich, M. G.; Rich, D. H. J. Med. Chem. 2002, 45, 541.
(2) Venkatesan, N.; Kim, B. H. Curr. Med. Chem. 2002, 9, 2243.
(3) Masse, C. E.; Knight, B. S.; Stavropoulos, P.; Panek, J. S. J. Am. Chem.
Soc. 1997, 119, 6040.
(4) (a) Wipf, P.; Xiao, J. Org. Lett. 2005, 7, 103. (b) Wipf, P.; Henninger, T.
C. J. Org. Chem. 1997, 62, 1586. (c) Wipf, P.; Fritch, P. C. J. Org. Chem.
1994, 59, 4875.
(5) Wipf, P.; Henninger, T. C.; Geib, S. J. J. Org. Chem. 1998, 63, 6088.
(6) (a) Grotenbreg, G. M.; Kronemeijer, M.; Timmer, M. S. M.; El Oualid,
F.; van Well, R. M.; Verdoes, M.; Spalburg, E.; van Hooft, P. A. V.; de
Neeling, A. J.; Noort, D.; van Boom, J. H.; van der Marel, G. A.;
Overkleeft, H. S.; Overhand, M. J. Org. Chem. 2004, 69, 7851. (b)
Grotenbreg, G. M.; Timmer, M. S. M.; Llamas-Saiz, A. L.; Verdoes, M.;
van der Marel, G. A.; van Raaij, M. J.; Overkleeft, H. S.; Overhand, M.
J. Am. Chem. Soc. 2004, 126, 3444.
(7) Yamada, K.; Unno, M.; Kobayashi, K.; Oku, H.; Yamamura, H.; Araki,
S.; Matsumoto, H.; Katakai, R.; Kawai, M. J. Am. Chem. Soc. 2002, 124,
12684.
Figure 2. Circular dichroism spectra of 9a, 9b, and Cbz2GS in EtOH.
(8) (a) Kondejewski, L. H.; Farmer, S. W.; Wishart, D. S.; Hancock, R. E.
W.; Hodges, R. S. Int. J. Pept. Protein Res. 1996, 47, 460. (b)
Kondejewski, L. H.; Farmer, S. W.; Wishart, D.; Kay, C. M.; Hancock,
R. E. W.; Hodges, R. S. J. Biol. Chem. 1996, 271, 25261.
(9) (a) Wipf, P.; Kendall, C.; Stephenson, C. R. J. J. Am. Chem. Soc. 2001,
123, 5122. (b) Wipf, P.; Kendall, C.; Stephenson, C. R. J. J. Am. Chem.
Soc. 2003, 125, 761.
(10) (a) Wipf, P.; Jahn, H. Tetrahedron 1996, 52, 12853. (b) Wipf, P.; Kendall,
C. Top. Organomet. Chem. 2004, 8, 1.
(11) Edmonds, M. K.; Abell, A. D. J. Org. Chem. 2001, 66, 3747.
(12) The configuration was assigned by X-ray analysis of 5a.
(13) (a) Chen, Q.-Y.; Wu, S.-W. Chem. Commun. 1989, 705. (b) Fei, X.-S.;
Tian, W.-S.; Chen, Q.-Y. J. Chem. Soc., Perkin Trans. 1 1998, 1139.
(14) De Luca, L.; Giacomelli, G.; Porcheddu, A. Org. Lett. 2001, 3, 3041.
(15) (a) Wipf, P.; Fritch, P. C.; Geib, S. J.; Sefler, A. M. J. Am. Chem. Soc.
1998, 120, 4105. (b) Imperiali, B.; Fisher, S. L.; Moats, R. A.; Prins, T.
J. J. Am. Chem. Soc. 1992, 114, 3182.
(16) (a) Tamaki, M.; Akabori, S.; Muramatsu, I. Bull. Chem. Soc. Jpn. 1993,
66, 3113. (b) Woody, R. W. In Circular Dichroism; Nakanishi, K., Berova,
N., Woody, R. W., Eds.; VCH: New York, 1994; Chapter 17, pp 473-
496.
Figure 3. X-ray structure of 9b: (A) side view; (B) top view of four
molecules (side chains were truncated for clarity).
tively) between NH(Leu) and CdO(Val) that is typical of GS
(Figure 3). The DPhe-Pro type II′ â-turn has an ideal set of dihedral
angles (φ2 ) 137°, ψ2 ) -95°, φ3 ) -82°, ψ3 ) -5.7°) and is
apparently not perturbed by the adjacent CF3-substituted (E)-
alkene.17 The plane of the double bond is, however, twisted by 70°
away from the interior of the â-turn compared to that of the
analogous amide, leading to a fluorine-hydrogen distance of 4.2
Å to NH(Val), most likely due to the bulk of the CF3 group which
cannot easily be accommodated inside the hairpin. The rest of the
(17) Ball, J. B.; Hughes, R. A.; Alewood, P. F.; Andrews, P. R. Tetrahedron
1993, 49, 3467.
(18) For details of the antimicrobial assay, see: Porter, E. A.; Weisblum, B.;
Gellman, S. H. J. Am. Chem. Soc. 2002, 124, 7324.
JA051002S
9
J. AM. CHEM. SOC. VOL. 127, NO. 16, 2005 5743